1. Home
  2. RCUS vs BBSI Comparison

RCUS vs BBSI Comparison

Compare RCUS & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • BBSI
  • Stock Information
  • Founded
  • RCUS 2015
  • BBSI 1965
  • Country
  • RCUS United States
  • BBSI United States
  • Employees
  • RCUS N/A
  • BBSI N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • RCUS Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • RCUS Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • RCUS 1.2B
  • BBSI 1.1B
  • IPO Year
  • RCUS 2018
  • BBSI 1993
  • Fundamental
  • Price
  • RCUS $13.90
  • BBSI $44.59
  • Analyst Decision
  • RCUS Buy
  • BBSI Strong Buy
  • Analyst Count
  • RCUS 7
  • BBSI 3
  • Target Price
  • RCUS $22.00
  • BBSI $46.33
  • AVG Volume (30 Days)
  • RCUS 937.9K
  • BBSI 152.1K
  • Earning Date
  • RCUS 11-05-2025
  • BBSI 11-05-2025
  • Dividend Yield
  • RCUS N/A
  • BBSI 0.72%
  • EPS Growth
  • RCUS N/A
  • BBSI 10.14
  • EPS
  • RCUS N/A
  • BBSI 2.03
  • Revenue
  • RCUS $262,000,000.00
  • BBSI $1,199,321,000.00
  • Revenue This Year
  • RCUS N/A
  • BBSI $10.96
  • Revenue Next Year
  • RCUS N/A
  • BBSI N/A
  • P/E Ratio
  • RCUS N/A
  • BBSI $22.03
  • Revenue Growth
  • RCUS 6.07
  • BBSI 9.48
  • 52 Week Low
  • RCUS $6.50
  • BBSI $35.81
  • 52 Week High
  • RCUS $18.98
  • BBSI $49.65
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 68.53
  • BBSI 41.31
  • Support Level
  • RCUS $12.89
  • BBSI $43.35
  • Resistance Level
  • RCUS $16.12
  • BBSI $45.41
  • Average True Range (ATR)
  • RCUS 0.73
  • BBSI 0.96
  • MACD
  • RCUS 0.07
  • BBSI -0.09
  • Stochastic Oscillator
  • RCUS 44.17
  • BBSI 32.13

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: